Surrozen, Inc. has grown revenue −35% a year over three years. Revenue growth, 3-year annual rate: −35% (Biotechnology median +17%). Years of annual history on file: 6, FY2020 to FY2025, as filed.

SRZNSurrozen, Inc.

Healthcare

$28.01+104% 1Y

$28.01

$11.8052 weeks$34.13

Is it growing?

Watch

Growth is fading: revenue shrinking (−9% year on year) and operating margin narrowing (−182.3 points).

2 to watch, 1 without data

Revenue trend−9% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−182.3 points operating

Trailing-twelve-month operating margin, -979.4% now against -797.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.